Jasper Therapeutics Inc. (JSPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -75,801 | -66,700 | -47,964 | -21,241 | -71,269 |
| Depreciation Amortization | 1,056 | 766 | 537 | 279 | 1,373 |
| Accounts payable and accrued liabilities | 2,193 | 5,139 | 4,007 | -1,039 | -122 |
| Other Working Capital | -4,923 | 4,807 | 4,994 | -3,884 | 184 |
| Other Operating Activity | 314 | 694 | 131 | 3,043 | 7,232 |
| Operating Cash Flow | $-77,161 | $-55,294 | $-38,295 | $-22,842 | $-62,602 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 5 | 5 | 5 | 4 | -532 |
| Investing Cash Flow | $5 | $5 | $5 | $4 | $-532 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 34,211 | 34,551 | 6,163 | N/A | 47,884 |
| Financing Cash Flow | $34,211 | $34,551 | $6,163 | $N/A | $47,884 |
| Beginning Cash Position | 72,054 | 72,054 | 72,054 | 72,054 | 87,304 |
| End Cash Position | 29,109 | 51,316 | 39,927 | 49,216 | 72,054 |
| Net Cash Flow | $-42,945 | $-20,738 | $-32,127 | $-22,838 | $-15,250 |
| Free Cash Flow | |||||
| Operating Cash Flow | -77,161 | -55,294 | -38,295 | -22,842 | -62,602 |
| Capital Expenditure | -7 | -7 | -7 | N/A | -552 |
| Free Cash Flow | -77,168 | -55,301 | -38,302 | -22,842 | -63,154 |